Mind\xa0Medicine (MindMed) Inc. (OTCQB: MMEDF) is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic inspired\xa0medicines to offer solutions to address mental health issues including anxiety, addiction, and depression. CEO, JR Rahn, provides a perspective on\xa0how the current social and economic climate\xa0correlates with mental health and\xa0Mind\xa0Med\u2019s\xa0mission to provide\xa0therapeutic benefits of psychedelics to resolve mental illness.\xa0\xa0